controversy News

Most Popular controversy Story

Cepheid cashes in on MRSA trends--for now

March 7, 2008 — 6:59am ET

With cases of antibiotic-resistant MRSA multiplying and fear of the superbug rising, Cepheid Read more...

Latest Headlines

In Austin, VC is booming for biotechs
March 28, 2008
Cepheid cashes in on MRSA trends--for now
March 7, 2008
Experts debate FDA signals on cancer drug approval
March 4, 2008
Financial conflicts raise questions over trial results
January 30, 2008
ALSO NOTED: Cardiome awaits FDA decision; Congress to investigate Vytorin scandal; and much more...
January 18, 2008
Human embryo clones unveiled by CA scientists
January 17, 2008
Foundation draws charges of industry influence
January 7, 2008
Mass. Bio members distraught over new controversy
September 5, 2007
Texas'$3B cancer program draws controversy
September 4, 2007
Gilead touts Phase III Hep B results
June 24, 2007
SPOTLIGHT: Finneran resigns from council
January 9, 2007
Northfield shares hammered on late-stage results
December 19, 2006
FDA puts hold on Phase II anthrax vaccine trial
November 2, 2006
NIH group accuses Lilly of manipulating guidelines
October 18, 2006
Report: Project BioShield fails to deliver
September 17, 2006
Gene therapy makes a big comeback
August 27, 2006
FDA clears Plan B, ending FDA confirmation fight
August 23, 2006
Hedge fund blasts Nabi management, demands sale
August 16, 2006
Biovail trading halted on generic court decision
August 1, 2006
Biovail chairman charged with securities violations
July 31, 2006

Paid Research Reports

More Research Reports >>